News and Trends 5 Oct 2022
CanSinoBIO to present latest data on inhaled COVID vaccine
CanSino Biologics Inc. will be presenting clinical trial data for the recombinant COVID-19 vaccine (adenovirus type 5 vector) for inhalation (with the trade name Convidecia Air) at World Vaccine Congress (WVC) Europe to be held October 11 to 14, 2022 in Barcelona, Spain. Jean-Denis Shu, vice president for medical affairs of CanSino Biologics will be […]